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Cardiac function was evaluated in 24 children from a
Jamaican sickle cell cohort study. Ten patients with sickle
cell disease underwent echocardiographic studies on their
eighth birthday. The results were compared with 14 age-
and sex-matched control children born within hours of
the index patients. Left ventricular dimension index (sys-
tolic 2.89 ± 0.31 versus 2.33 ± 0.42 em and diastolic
4.70 ± 0.35 versus 3.64 ± 0.48 em, p =0.001), diastolic
volume (79.4 ± 17.1 versus 60.8 ± 7.8 ml, p = 0.01),
left ventricular mass index (116.3 ± 3.4 versus 74.3 ±
15.2 g/m", p = 0.001) and cardiac index (5.51 ± 1.32
versus 3.38 ± 0.85 liters/min per m2 p = 0.001) were
significantly increased in patients with sickle cell disease
compared with values in control subjects. However, there
was no statistically significant difference between the two
groups for ejection fraction, velocity of circumferential
fiber shortening, percent fractional shortening, systolic
Adults with homozygous sickle cell disease generally man-
ifest cardiomegaly, flow murmurs and evidence of an in-
creased cardiac output. These changes are presumed to be
part of cardiovascular adaptation to chronic anemia and there
is some evidence that cardiomegaly is more marked in pa-
tients with the lowest hemoglobin levels (I). Recent pro-
spective studies by Serjeant et al. (2) showed that hemo-
globin levels of children with sickle cell disease followed
up from birth decrease to levels characteristic of adults by
I year of age. However, the age at which cardiac changes
develop in sickle cell disease is unknown and the limited
data available in children are inevitably derived from symp-
tomatically biased groups of patients. This selection bias
has led to conflicting results. Our study is an attempt to
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time intervals, wall stress and ratio of wall stress-systolic
volume. Although two mean ratios of wall stress-systolic
volume index were lower in children with sickle cell
disease as compared with control subjects (4.0 ± 0.7
versus 5.4 ± 1.7, P = 0.02 and 5.9 ± 1.2 versus 8.3
± 2.5, P = 0.005, respectively), the range of ratios
remained within normal limits (3.4 to 5.8 in children
with sickle cell disease versus 2.8 to 9.5 in controls and
4.2 to 8.3 versus 3.8 to 12.5, respectively). Furthermore,
only body surface area predicted group status indepen-
dent of other variables (p = 0.01).
In conclusion, left ventricular contractile function re-
mains normal in asymptomatic children with sickle cell
disease in the first 8 years of life, despite an increase in
end-diastolic volume.
(J Am Coil CardioI1987;9:1038-42)
evaluate left ventricular function in an unbiased asympto-
matic group of children with sickle cell disease.
The Jamaican sickle cell cohort study, on the basis of
neonatal screening, has identified a representative sample
of children with sickle cell disease who are being followed
up prospectively along with age- and sex-matched control
children with a normal hemoglobin genotype. Echocardio-
graphic studies have been performed in a sample of these
patients and control subjects at the age of 8 years to deter-
mine what cardiac changes are apparent by that age.
Methods
Study patients. The children were part of the Jamaican
sickle cell cohort study, which includes all cases of sickle
cell disease among 100,000 consecutive normal deliveries
screened at the main Government Maternity Hospital (Vic-
toria Jubilee Hospital) in Kingston, Jamaica between June
1973 and December 1981. The first 125 patients with sickle
cell disease were each matched with two control groups
with a normal hemoglobin genotype of the same sex who
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Table 1. Clinical and Hematologic Data
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Variable
Hb (g/dl)
Height (cm)
Weight (kg)
BSA (rrr')
Systolic BP (mm Hg)
Diastolic BP (mm Hg)
SS Disease
(n = 10)
(mean ± SO)
7.79 ± 0.64
122.3 ± 6.6
20.8 ± 2.8
0.85 ± 0.08
101 ± 5
55 ± 7
AA Controls
(n = 14)
(mean ± SO)
12.0 ± 0.52
129.4 ± 4.2
24.5 ± 1.8
0.99 ± 0.14
97 ± 8
60 ± 10
p Value
0.01
0.01
0.001
0.006
NS
NS
AA = homozygous hemoglobin A; BP = blood pressure; BSA = body surface area; Hb = hemoglobin;
SS = homozygous hemoglobins.
were born within hours of the index case. The diagnostic
methods, methods of follow-up and techniques of hema-
tologic procedures have been presented elsewhere (2-4).
The patient's weight was measured on a lever balance with
light clothing but with shoes removed, and their height was
measured on a standing height stadiometer. Body surface
area was estimated from nomograms derived from normal
populations (Geigy statistical tables).
The study was conducted between August and October
1981, at which time the first 14cohorts were within 2 months
of their eighth birthday. Of these 14, 2 had died and 2 were
living in the country remote from Kingston. Studies were
performed in the remaining 10 patients. Of the 28 matched
control children, 7 were unavailable (I emigrated, 2 died,
2 were living in the country and 2 defaulted on follow-up).
Appointments were given to the remaining 21, of which If
attended.
Echocardiographic measurements. M-mode echo-
cardiography was performed using a Smith-Kline Ekoline
Ultrasonoscope 20 and a strip chart recorder. A 3.5 MHz
focused (5 em) transducer with an active crystal diameter
of 1.27 ern was used. The children were examined in the
supine position with the transducer along the third to fifth
left sternal border. Examinations were performed by one of
two cardiologists (E.C. or S.D.), neither of them aware of
which children were patients and which were controls. Re-
cordings and measurements were made according to the
criteria of the American Society of Echocardiography (5).
An index of agreement between measurements performed
by the two cardiologists was derived from the interclass
Table 2. Measured and Derived Echocardiographic Indexes in the Two Groups
Indexes
LV end-diastolic dimension
(cm)
LV end-systolic dimension
(ern)
Interventricular septal
thickness (ern)
LV posterior wall (cm)
RV anterior wall (ern)
Aortic root (ern)
Aortic valve opening (cm)
Left atrium (cm)
LVend-diastolic dimension
index (cm/rrr')
LV end-systolic dimension
index (cm/rrr'}
LV systolic volume (rnl)
LVVls (ml/rrr')
LV end-diastolic volume
(m!)
LV mass (g)
LV mass index (g/rrr')
Cardiac index (liters/rrr')
55 Disease
(mean ± SO)
3.99 ± 0.40
2.53 ± 0.28
0.72 ± 0.19
0.66 ± 0.13
0.27 ± om
1.98 ± 0.51
1.74 ± 0.25
2.90 ± 0.33
4.70 ± 0.35
2.89 ± 0.31
15.3 ± 4.4
18.1 ± 4.7
79.4 ± 17.1
99.2 ± 26.6
116.3 ± 31.4
5.51 ± 1.32
AA Controls
(mean ± SO)
3.56 ± 0.21
2.31 ± 0.23
0.64 ± 0.10
0.65 ± 0.12
0.28 ± 0.07
1.74 ± 0.29
1.54 ± 0.12
2.46 ± 0.34
3.64 ± 0.48
2.33 ± 0.42
12.1 ± 4.2
12.6 ± 4.9
60.8 ± 7.8
72.1 ± 15.4
74.3 ± 15.2
3.38 ± 0.85
p Value
0.01
0.05
NS
NS
NS
NS
0.05
0.01
0.001
0.001
NS
0.02
0.01
0.01
0.001
0.001
LV = left ventricular; LVVls left ventricular systolic volume index; RV = right ventricular; other
abbreviations as in Table I.
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correlationcoefficient utilizingFisher's analysisof variance.
There was a good agreement between interobserver mea-
surements for left ventricular diastolic dimension (correla-
tion coefficient r = 0.99, p = 0.001 and a mean absolute
difference between determinations of 1%), systolic dimen-
sion (r = 0.98, p = 0.001 and a mean absolute difference
of I%), posterior wall and septum (r = 0.86, p = 0.001
and a mean absolute difference of 0.6%), left atrial size (r
= 0.999, p = 0.001, a mean absolute difference of 0.2%),
aortic root (r = 0.98, P = 0.00 I, a meanabsolutedifference
1.4%) and right ventricular diastolic dimension (r = 0.81,
P = 0.001, a mean absolute difference of 3.2%).
The left ventricular dimensions were measured from a
pointjust below the mitral leaflets at the levelof the chordae
tendineae. The left ventricularend-diastolicdimension (Dd)
was measured at the onset of the QRS complex of the elec-
trocardiogram, and the systolic dimension at the point of
maximal posterior movement of the ventricular septum.
Left ventricular end-diastolic volume and ejection frac -
tion were estimated by the methods of Meyeret al. (6). Left
ventricular end-diastolic volume (LVEOV) was estimated
from the regression equation
L VEDV = - 19.1 + 14.6 Dd + 0.62 Dd '.
whereDd representsleft ventricularend-diastolicdimension
(6) .
Left ventricular ejection fraction (LVEF) was estimated
from the formula
LVEF = [ - (A s/Ad) x (Ds/Dd/),
where As/Ad is the ratio of end-systolic and end-diastolic
left ventricular major axis dimensions and is assumed to be
0.9, corresponding to a 10% shortening of this axis and Os
represents the left ventricular end-systolic dimension (6).
Left ventricular mass (LV mass) was calculated from the
cube method as follows (7):
LV ma ss = (1.05) [(LVDd + IVS + LVPW)3 - (LVDd)3].
where IVS is the wall thickness of the interventricular sep-
tum, LVPW is thickness of left ventricular posterior wall
and LVOd is the minor axis left ventricular diameter, all
taken at end-diastole (5).
Cardiac output was calculated from the stroke volume
and heart rate (the stroke volume was derived from the
productof left ventricular end-diastolic volume and ejection
fraction) .
Systolic time intervals were calculated from the echo-
cardiographic recordings, with the left ventricular ejection
time being defined as the interval between opening and
closing of the aortic valve, and the left ventricular pre-
ejection period as the time from the Q wave of the electro-
cardiogram to the start of the opening of the aortic valve
(8). Right ventricular ejection time and pre-ejection period
were similarly calculated from the pulmonary valve echo-
gram and the electrocardiogram.
Left ventricular end-systolic wall stress was calculated
by the method of Reicheck et al. (9). End-systolic stress
index was calculatedby the method of Quinoneset al. (10).
Stress to volume and stress-volume index ratios were then
determined.
Statistics. Statistical analysis for comparison between
patientsand control subjects was performedusing Student's
Table 3. Left Ventricular Function Ind exes in the Two Groups
SS Disease AA Controls
Indexes (mean ± SO) (mean ± SO) P Value
Heart rate 95 ± 9 87 ± 14 NS
Fractional shortening ( 'Yo ) 37 ± 6 35 ± 4 NS
Circumferential fiber 1.29 ± 0.23 1.25 ± 0.19 NS
shortening (circ/s)
LV ejection fraction ( 'Yo ) 63 ± 6 62 ± 5 NS
End-systolic stress 70 ± 17 65 ± 23 NS
( X 103 dynes/cm -)
End-systolic stress index 103 ± 15 95 ± 21 NS
(mm Hg)
ESS/LVV 4.8 ± 1.1 5.4 ± I.l NS
ESS/LVVI 4.0 ± 0.7 5.4 ± 1.7 0.0 2
ESIILVV 7. J ± 1.8 8.4 ± 2.0 NS
ESIILVVI 5.9 ± 1.2 8.3 ± 2.5 0.005
RVPEP/RVET 0.23 ± 0.05 0.22 ± 0.04 NS
LVPEP/LVET 0.29 ± 0.02 0.29 ± 0.Q3 NS
eire = circumference ; ESI/LVV = end-systolic stress index and left ventricular systolic volume ratio;
ESIILVVI = end-systolic stress index and left ventricular systolic volume index ratio; ESS/LVV = end-
systolic stress and left ventricular systolic volume ratio; ESS/LVVI = end-systolic stress and left ventricular
systolic volume index; LV = left ventricular; LVPEP/LVET = left ventricular pre-ejection period and ejection
time ratio; RVPEP/RVET = right ventricular pre-ejection period and eject ion time ratio; other abbreviations
as in Table I .
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t test and analysis of variance. Significant difference was
defined as a probability (p) value :5 0.05 .
Results
Clinical data. There were 10 children with sickle cell
disease (6 male, 4 female) and 14 control children (8 male.
6 female) all of whom were within 2 months of their eighth
birthday at the time of study. Hematologic and anthropo-
metric data (Table I) indicate significantly lower hemoglo-
bin levels. height, weight and body surface area in the
children with sickle cell disease.
Echocardiographic data. Cardiac measurements and
derived indexes are shown in Table 2 and details of left
ventricular function and systolic time intervals in Table 3.
Left ventricular systolic and diastolic dimensions, aortic
valve opening and left atrial size were significantly increased
in children with sickle cell disease. The derived indexes of
left ventricular end-diastolic volume, left ventricular end-
diastolic minor axis dimension index, left ventricular mass
and cardiac index were all significantly greater in the chil-
dren with sickle cell disease.
Ventricular function. There were weak but signifi cant
negative correlations between hemoglobin level and cardiac
index in both patients and controls (p = 0.05 ). but no
significant correlations between hemoglobin and end-dia-
stolic volume. ejection fraction or pulse rate. Furthermore.
there was no statistical significance in indexes of cardiac
function between the two groups (Table 3), except for the
ratio between end-systolic wall stress and left ventricular
systolic volume index (p = 0.02) and the ratio between
end-systolic stress index and left ventricular systolic volume
index (p = 0.005). Of all the variables indicated. only body
surface area significantly predicted group status independent
of other variables (p = 0.01).
Discussion
Echocardiography is a simple noninvasive tool for as-
sessing cardiac dimensions and function. Its indirect nature
implies that approximations are necessary in some mea-
surements and that indexes must be derived from complex
formulas rather than direct measurements. These formulas
have generally been well substantiated from autopsy, an-
giographic and hemodynamic data. Within these limitations.
echocardiography gives very useful information that would
not otherwise be available.
Previous studies. Cardiac size and function in sickle
cell disease have been previously studied ( 11-15) by echo-
cardiography and by radionuclide ventriculography (16.17).
Most of these studies were performed on adults and only
one (12) was confined to children. From these studies, there
is general agreement that cardiac dimensions, left ventric-
ular volume and mass and cardiac output are increased in
subjects with sickle cell anemia. These observations are
consistent, regardless of age. However, the age at which
cardiac enlargement develops is unknown, although it may
well be in the first few years of life. Our study has shown
that in patients with sickle cell anemia. left ventricular di-
astolic and systolic dimensions and dimension index, dia-
stolic volume. left ventricular mass and cardiac index are
significantly increased by the age of 8 years compared with
values in control subjects (Table 2). .
Ventricular function variables. Data on indexes of left
ventricular function, however, are conflicting. Ejection frac-
tion in most adult studies has been normal (11,14-17) ,
although Val-Mejias et al. (l Jlnoted ejection fraction to be
normal in patients under 23 years of age but to decrease
after this age. Velocity of circumferential fiber shortening,
percent shortening and systolic time indexes in these adult
studies have also been predominantly normal. In our study,
ejection fraction, velocity of circumferential fiber shorten-
ing. percent fractional shortening, systolic time indexes,
wall stress and wall stress-systolic volume ratios were found
to be similar to those of age-matched control children with
normal hemoglobin.
The studv hy Rees et al . (12) stands in sharp contrast to
this general experience . In a group of 44 children with sickle
cell disease aged 2 to 14 years, compared with 28 randomly
selected normal black children of comparable age, ejection
fraction. circumferential fiber shortening and percent frac-
tional shortening were significantly reduced in the sickle
cell group. Further analysis indicated that this difference
was entirely due to a symptomatic subgroup of 35 children
who reported dyspnea or fatigue, or both. at rest or during
mild activity. On the other hand, indexes of nine asymp-
tomatic children with sickle cell disease did not differ from
those in the control group. The confl ict between apparently
normal studies of cardiac function in adults and the high
prevalence of abnormal function noted by Rees et al, (12)
in children could only be reconciled by improving cardiac
function with age, death of the severely affected children
so that only those with normal function survive or selection
biases resulting in unusually severely affected children or
unusually mildly affected adults. The first explanation is
pathologically unlikely and the second would require a high
mortality rate from cardiac causes among children, a trend
that has not been observed (1.2 ,18,19) . The apparently nor-
mal cardiac function in a representative sample of 10 sub-
jects with sickle cell disease in our study raises the question
of a symptomatic bias in the patients studied by Rees et al.
( 12). Is it possible that a substantial proportion of children
were referred for the investigation of cardiac symptoms?
Although our present study is small, the method of ascer-
tainment yields information that is not subject to such biases.
Implications. Our study, along with others performed
in adult groups, suggests that despite increased cardiac di-
mensions and cardiac output in sickle cell disease, left ven-
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tricular function is generally normal. This conclusion is
based on ejection fraction, velocity of circumferential fiber
shortening, percent fractional shortening and systolic time
indexes that do not differ significantly from those in control
groups. Use of systolic time indexes as an indicator of left
ventricular function was questioned by Denenberg et al.
(15), who suggested that under the altered loading condi-
tions of chronic anemia, a normal ejection fraction may be
maintained even in the presence of compromised left ven-
tricular function. These authors argued that cardiac dilation
increased preload and that decreased peripheral resistance
reduced the afterload, both factors tending to increase ejec-
tion fraction. They recommended that more appropriate in-
dicators of left ventricular function independent of time
intervals should be utilized instead. Using rest end-systolic
stress-systolic volume index and the slope of end-systolic
stress versus end-systolic volume index relation as indicators
of left ventricular performance, Sagawa et al, (20) found
both to be significantly decreased in patients with sickle cell
disease compared with controls.
Our data on mean end-systolic wall stress-systolic vol-
ume index and end-systolic stress index-systolic volume
index ratios confirm these findings. However, only body
surface area significantly predicted group status independent
of other variables (p = 0.01). All the ratios from children
with sickle cell disease were within a normal range (3.4 to
5.8 for patients versus 2.8 to 9.2 for control subjects for
end-systolic stress/left ventricular volume index and 4.2 to
8.3 for patients versus 3.8 to 12.5 for control subjects for
end-systolic stress indexlleft ventricular volume index). Al-
though the respective mean ratios were statistically lower
in children with sickle cell disease compared with control
subjects (Table 3), it appears that in this group of patients,
left ventricular performance remains within a normal range
up to 8 years of age.
Future directions. Although the numbers are small, our
study has made an attempt to exclude a symptomatic bias.
More large scale studies on cardiac function in both children
and adults with sickle cell disease are needed, however, and
these should use alternatives to the systolic time indexes,
which may be unreliable in the presence of chronic anemia.
End-systolic wall stress and end-systolic stress index nor-
malized to left ventricular systolic volume index are prom-
ising markers of ventricular function. Longitudinal studies
of these indexes may clarify the natural history of left ven-
tricular performance in children and adults with sickle cell
anemia.
We thank Eric Cottington, PhD of the Biostatistics Department of Alle-
gheny-Singer Research Institute for assistance on the statistical aspects of
this paper.
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